Lipoplatin Combined With Cisplatin. At Least As Effective As The 'Old Classic' Paclitaxel Combined With Cisplatin In Non-Small-Cell Lung Cancer (NSCLC), And Surely Less Toxic

Autor:	Michalis Toumbis, Maria Krifti, Agisilaos Dervas, Ioannis Dimitroulis, Georgios T. Stathopoulos
Rok vydání:	2011
Předmět:	Oncology Cisplatin medicine.medical_specialty business.industry Lipoplatin non-small cell lung cancer (NSCLC) medicine.disease chemistry.chemical_compound Paclitaxel chemistry Internal medicine medicine business medicine.drug
Zdroj:	B44. LUNG CANCER: ADVANCES IN IMAGING, BIOMARKERS, SCREENING, AND TREATMENT.
DOI:	10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3050
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::fe82813be3d8485587fd0b7187e08e2c https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3050 Zobrazit plný text záznamu